Core Laboratories (CLB) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
CORE LAB REPORTS SECOND QUARTER 2022 RESULTS FROM CONTINUING OPERATIONS
July 27, 2022 5:15 PM EDTSECOND QUARTER REVENUE OF $120.9 MILLION; UP 5% SEQUENTIALLY; UP 2% YEAR-OVER-YEARSECOND QUARTER SEQUENTIAL INCREMENTAL MARGINS, EX-ITEMS, 43%, DRIVEN BY RESERVOIR DESCRIPTIONSECOND QUARTER GAAP EPS OF $0.15; EPS, EX-ITEMS, $0.12RENEWS AND EXTENDS REVOLVING CREDIT FACILITY THROUGH 2026ANNOUNCES Q3 2022 QUARTERLY DIVIDEND
AMSTERDAM, July 27, 2022 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported second quarter 2022 revenue of $120,900,000. Sequential revenue growth was adversely impacted by approximately... More
